gallium has been researched along with gallium nitrate in 248 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (13.71) | 18.7374 |
| 1990's | 111 (44.76) | 18.2507 |
| 2000's | 45 (18.15) | 29.6817 |
| 2010's | 47 (18.95) | 24.3611 |
| 2020's | 11 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Akerström, G; Gylfe, E; Hellman, P; Ljunggren, O; Ljunghall, S; Rastad, J; Ridefelt, P | 1 |
| Antholine, WE; Chitambar, CR; Narasimhan, J | 1 |
| Crawford, ED; Moran, PL; Schleicher, RB; Seligman, PA | 1 |
| Apseloff, G; Cox, K; Gerber, N; Jewell, S; Matkovic, V; Whitacre, C | 1 |
| Lakatos, P; Stern, PH; Tatrai, A | 1 |
| Logothetis, C | 1 |
| Apseloff, G; Gerber, N; Whitacre, C | 1 |
| Corbella, J; Domingo, JL; Gómez, M; Sánchez, DJ | 1 |
| Bilezikian, JP | 2 |
| Apseloff, G; Gerber, N; Girten, B; Matkovic, V; Shepard, DR | 1 |
| Hansen, LA; Hughes, TE | 1 |
| Chitambar, CR; Sax, D | 1 |
| Burns, LA; Munson, AE; Saady, JJ; Sikorski, EE | 1 |
| Chitambar, CR; Lundberg, JH | 1 |
| Fitton, A; Todd, PA | 1 |
| Baker, LH; Bukowski, RM; Costanzi, JH; Crawford, ED; Saiers, JH | 1 |
| Lakatos, P; Mong, S; Stern, PH | 1 |
| Vogelzang, NJ | 1 |
| Adelson, MD; Blessing, JA; Malfetano, JH | 1 |
| Alfrey, AC; Flowers, WE; Horton, C; Levy, RJ; Schoen, FJ; Webb, CL | 1 |
| Heller, G; Murphy, WK; O'Dwyer, PJ; Schulman, P; Warrell, RP | 1 |
| Leyland-Jones, B | 2 |
| Bockman, RS | 1 |
| Warrell, RP | 2 |
| Krakoff, IH | 1 |
| Bajorin, DF; Bosl, GJ; Dershaw, DD; Heinemann, MH; Scher, HI; Seidman, AD; Silverberg, M; Sternberg, CN | 1 |
| Crawford, ED; Seligman, PA | 1 |
| Apseloff, G; Gerber, N; Matkovic, V; Shepard, DR | 1 |
| Apseloff, G; Gerber, N; Matkovic, V; Shepard, D | 1 |
| Bockman, RS; Boskey, AL; Donnelly, R; Doty, SB | 1 |
| Blessing, JA; Hanjani, P; Homesley, HD; Malfetano, JH | 1 |
| Bockman, RS; Jones, KW; Levine, B; Pounds, JG; Schidlovsky, G; Warrell, RP | 1 |
| Wisneski, LA | 1 |
| Antholine, WE; Chitambar, CR; Narasimhan, J; Zivkovic-Gilgenbach, Z | 1 |
| Frank, ML | 1 |
| Bockman, RS; Bosco, B; Lane, J; Levine, B; Warrell, RP; Weinerman, S | 1 |
| Arteaga, CL; Brown, TD; Craig, JB; Harman, GS; Koeller, JM; Kuhn, JG; Von Hoff, DD; Weiss, GR | 1 |
| Kanayama, S; Kohno, H; Kubodera, A; Ohkubo, Y | 1 |
| Bockman, RS; Warrell, RP | 1 |
| Bergeron, R; Honeysett, JM; Taetle, R | 1 |
| Fraschini, G; Frye, D; Holmes, FA; Hortobagyi, G; Jabboury, K | 1 |
| Alcock, NW; Bockman, RS; Issacs, M; Warrell, RP | 1 |
| Alcock, NW; Blumenthal, NC; Bockman, RS; Boskey, AL; Warrell, RP | 1 |
| Balsan, S; Bourdeau, A; Bourdon, R; Cournot-Witmer, G; Enault, G; Lieberherr, M; Plachot, JJ; Thil, CL | 1 |
| Bonjour, JP; Jung, A; Rizzoli, R | 1 |
| Hedley, DW; Mann, GJ; Slowiaczek, P; Tripp, EH | 1 |
| Bockman, RS; Frisone, M; Gaynor, JJ; Israel, R; Snyder, T; Warrell, RP | 1 |
| Alcock, N; Chan, E; Curley, T; Dershaw, D; Geller, N; Hollander, P; Nisselbaum, J; Scher, HI; Yagoda, A | 1 |
| Bartolucci, A; Carpenter, JT; Feagler, J; Keller, J | 1 |
| Clagett-Carr, K; Foster, BJ; Hoth, D; Leyland-Jones, B | 1 |
| Corbella, J; Domingo, JL; Llobet, JM | 1 |
| Alcock, NW; Bockman, RS; Skelos, A; Warrell, RP | 1 |
| Atkins, C; Coonley, CJ; Danieu, L; Warrell, RP | 1 |
| Alcock, NW; Bockman, RS; Warrell, RP | 1 |
| Fettman, MJ; Rollin, RE | 1 |
| Alcock, NW; Bockman, RS; Coonley, CJ; Isaacs, M; Warrell, RP | 1 |
| Casper, ES; Michaelson, RA; Parente, R; Sordillo, PP; Stanton, GF; Vinceguerra, V | 1 |
| Powis, G | 1 |
| Chitambar, CR; Massey, EJ; Seligman, PA | 1 |
| Bhalla, RB; Coonley, CJ; Farag, F; Leyland-Jones, B; Warrell, RP; Williams, L | 1 |
| Carter, SK | 1 |
| Bockman, RS; Coonley, CJ; Isaacs, M; Staszewski, H; Warrell, RP | 1 |
| Coonley, CJ; Straus, DJ; Warrell, RP; Young, CW | 1 |
| Baker, LH; Jones, SE; Stephens, RL; Weick, JK | 1 |
| Larson, SM; Nelson, NJ; Rasey, JS | 2 |
| Baker, LH; Fabian, CJ; Hynes, HE; Vaughn, CB | 1 |
| Baker, LH; Fabian, CJ; Fletcher, WS; Kraut, EH; Saiki, JH; Stephens, RL | 1 |
| Alcock, N; Brown, J; Kelsen, DP; Yeh, S; Young, C | 1 |
| Baker, LH; Fraile, RJ; O'Bryan, R; Samson, MK | 1 |
| Errante, D; Lenardon, O; Merlo, A; Santarossa, S; Tirelli, U; Vaccher, E | 1 |
| Ponka, P; Richardson, DR; Tran, EH | 1 |
| Roth, BJ | 2 |
| Chitambar, CR; Haq, RU; Wereley, JP | 1 |
| Capen, CC; Merryman, JI; Okada, H; Rosol, TJ | 2 |
| Harvey, HA | 1 |
| Akerström, G; Gylfe, E; Rastad, J; Ridefelt, P | 1 |
| Bekersky, I; Brown, NS; Ho, DH; Lee, F; Lin, JR; Mong, S; Newman, RA | 1 |
| Bitton, R; Bockman, RS; Bosco, BJ; Chausmer, A; Eyre, DR; Kotler, J; Levenson, D; Singer, F; Siris, E; Wilhelm, F | 1 |
| Bajorin, DF; Roth, BJ | 1 |
| Pecherstorfer, M; Raue, F | 1 |
| Hata, Y; Loehrer, PJ; Sandler, A; Sledge, GW; Weber, G | 1 |
| Chandler, JE; Ellender, G; Messer, HH | 1 |
| Bajic, DM; Chitambar, CR; Flores, RE; McAuliffe, TL; Schmidt, MH; Whelan, HT; Williams, MB | 1 |
| Ferguson, RM; Gabler, DM; Gerber, N; Huang, EH; Krecic, ME; Orosz, CG | 1 |
| Bockman, RS; Bosco, B | 1 |
| Colachis, SC; Popovich, PG; Stokes, B | 1 |
| Capen, CC; Merryman, JI; Rosol, TJ | 1 |
| Bajic, DM; Chitambar, CR; McAuliffe, TL; Segura, AD; Whelan, HT; Williams, MB | 1 |
| Apseloff, G; Gerber, N; Matkovic, V; Mays, DC; Shepard, DR; Stern, LS; Weisbrode, SE | 1 |
| Crown, JP; Warrell, RP | 1 |
| Cheson, BD | 1 |
| Canfield, VA; Lyss, AP | 1 |
| Bockman, RS; Guidon, PT; Kawaguchi, A; Pan, LC; Salvatori, R | 1 |
| Dilmanian, FA; Heelan, RT; Lovett, D; Schneider, R; Warrell, RP | 1 |
| Colomina, MT; Corbella, J; Domingo, JL; Llobet, JM; Sirvent, JJ | 1 |
| Betts, F; Bockman, R; Boskey, A; DiCarlo, E; Donnelly, R | 1 |
| Bahnson, RR; Corral, DA | 1 |
| Baran, DT; Jenis, LG; Lian, JB; Stein, GS; Waud, CE | 1 |
| Bockman, RS; Guidon, PT; Salvatori, R | 1 |
| Baselga, J; Heelan, RT; Kris, MG; Phillips, M; Scher, HI | 1 |
| Boskey, AL; Doty, SB; Guidon, P; Ziecheck, W | 1 |
| Hall, TG; Schaiff, RA | 1 |
| Bockman, RS; Weinerman, SA | 1 |
| Abraham, RT; Berggren, MM; Burns, LA; Powis, G | 1 |
| Dollard, PA; Lober, CA | 1 |
| Blessing, JA; Homesley, HD; Malfetano, JH | 1 |
| Ralston, SH | 1 |
| Apseloff, G; Bergese, SD; Ferguson, RM; Gerber, N; Mullet, D; Orosz, CG; VanBuskirk, AM; Wakely, E | 1 |
| Blum, R; Bonomi, P; Chang, AY; Smith, JL; Smith, TJ; Tu, ZN; Wiernik, PH | 1 |
| Orosz, CG | 1 |
| Abi-Aad, AS | 1 |
| Chisholm, MA; Mulloy, AL; Taylor, AT | 1 |
| Aoyagi, T; Bander, NH | 1 |
| Avis, I; Mulshine, JL; Neumann, RD; Weiner, RE | 1 |
| Chitambar, CR; Drobyski, WR; Majewski, D; Ul-Haq, R | 1 |
| Akansel, G; Akansel, S; Chitambar, CR; Collier, BD; Isitman, AT; Kitapci, MT; Krasnow, AZ; Liu, Y | 1 |
| Kemp, JD | 1 |
| Dixon, SC; Figg, WD; Giordano, C; Lush, RM; Reed, E; Venzon, D; Zalles, A | 1 |
| Chitambar, CR; Wereley, JP | 1 |
| Anderson, T; Chitambar, CR; Ritch, PS; Zahir, SA | 1 |
| Bergese, SD; Orosz, CG; Sedmak, DD; VanBuskirk, AM; Wakely, E | 1 |
| Orosz, CG; Sirak, J; VanBuskirk, AM; Wakely, E | 1 |
| Bajorin, DF; Heineman, M; Hilton, S; Hirsch, J; Kelly, WK; Mazumdar, M; McCaffrey, JA; Sadan, S; Scher, HI | 1 |
| Gross, AJ; Haschemi, R; Kallerhoff, M; Kugler, A; Ringert, RH; Zöller, G | 1 |
| Caruso, RC; Csaky, KG | 1 |
| Apseloff, G; Gerber, N; Hackshaw, KV; Weisbrode, SE; Whitacre, C | 1 |
| Elliott, RL; Head, JF; Wang, F | 1 |
| Chan, CC; Gerber, N; Gery, I; Kozhich, AT; Lobanoff, MC; Mullet, DI; Whitcup, SM | 1 |
| Fagbemi, SO; Stadler, WM | 1 |
| Christou, A; Dreicer, R; Einhorn, LH; Fox, S; Gonin, R; Loehrer, PJ; Meyers, T; Sandler, A; Weber, G | 1 |
| Orosz, CG; Sirak, JH; VanBuskirk, AM; Wakely, ME | 1 |
| Chitambar, CR; Elford, HL; Myette, MS | 1 |
| Boon, P; Chitambar, CR; Wereley, JP | 1 |
| Apseloff, G; Gerber, N; Krecic-Shepard, ME; Mullet, D; Shepard, DR; Weisbrode, SE | 1 |
| Abornathy, T; Figg, WD; Headlee, D; Horti, J; Lush, RM; Reed, E; Reid, R; Sausville, EA; Senderowicz, AM | 1 |
| Bishop, JF; Hillcoat, BL; Olver, IN; Sephton, RG; Stokes, KH; Webster, LK | 1 |
| Guidon, P; Kumar, E; Panagakos, FS; Venescar, C | 1 |
| Britigan, BE; Olakanmi, O; Schlesinger, LS | 1 |
| Edelman, MJ | 1 |
| Apseloff, G | 1 |
| Berenshtein, E; Chevion, M; Haverich, A; Karck, M; Sturm, C; Tanaka, S | 1 |
| Fulfaro, F; Ripamonti, C | 1 |
| Angulo, SJ; Ghazi, AM; Pashley, DH; Shuttleworth, S | 1 |
| Bockman, RS; Gallagher, RA; Guidon, PT; Hightower, LE; House, SD; Kyriakos, R; Mistry, T; Perdrizet, GA; Rewinski, M | 1 |
| Geis-Gerstorfer, J; Lang, F; Schweizer, K; Wagner, CA | 1 |
| Davidson, TG | 1 |
| Bockman, RS; Coico, JM; Esposito, D; Goncalves, J; Higgins, PJ; Schwartz, B; Staiano-Coico, L; Wasif, N | 1 |
| Choy, CG; Lyons, L; Michaeli, J; Niesvizkya, R; Siegel, D | 1 |
| McCarthy, AA | 1 |
| Goranov, SE; Simeonov, SB | 1 |
| Chitambar, CR | 6 |
| Bockman, R | 1 |
| Niesvizky, R | 1 |
| Straus, DJ | 1 |
| Einhorn, L | 1 |
| Jakupec, MA; Keppler, BK | 1 |
| Jasinski, J; Liliental-Weber, Z; Morkoc, H; O'Keefe, MA; Zakharov, D | 1 |
| Foss, F; Higgins, B; Huang, Z | 1 |
| Eby, G | 2 |
| Igaz, P; Tulassay, Z | 1 |
| Chitambar, CR; Davies, NP; Richardson, DR; Suryo Rahmanto, Y | 1 |
| Bernstein, LR; Cohen, ND; Harrington, JR; Martens, RJ | 1 |
| Arumugam, GP; Sachdanandam, P; Shanthi, P; Sundravel, S | 1 |
| Arumugam, G; Sachdanandam, P; Shanthi, P | 1 |
| Chitambar, CR; Matsuyama, S; Wereley, JP | 1 |
| Chitambar, CR; Kroft, SH; Yang, M | 1 |
| Chitambar, CR; Purpi, DP; Wereley, JP; Woodliff, J; Yang, M | 1 |
| Borro, LC; de Moraes, IG; Garcia, RB; Mori, GG; Purificação, BR | 1 |
| Eby, GA | 1 |
| Chitambar, CR; Yang, M | 1 |
| Elborn, JS; Goldsmith, CE; Loughrey, A; Millar, BC; Moore, JE; Murphy, A; Rooney, PJ | 1 |
| Balldin, F; DeLeon, K; Griswold, J; Hamood, A; Rumbaugh, KP; Sreedharan, S; Watters, C | 1 |
| Chen, GD; Wang, RM | 1 |
| Bytzek, A; Groessl, M; Hartinger, CG | 1 |
| Chitara, B; Ivan Jebakumar, DS; Krupanidhi, SB; Rao, CN | 1 |
| Bougerol, C; Daudin, B; Landré, O; Renevier, H | 1 |
| Bohn, PW; Duan, BK | 1 |
| Cho, CY; Han, SH; Kang, JW; Kang, SE; Kwon, MK; Lee, DY; Lee, SJ; Park, SJ | 1 |
| Bie, YQ; Dai, L; Deng, JJ; Han, XB; Laurent, K; Leprince-Wang, Y; Liao, ZM; Sang, LW; Wang, PW; Wu, XS; Xu, J; Ye, Y; Yu, DP; Zhao, Q; Zhou, YB | 1 |
| Eddy, CR; Hite, J; Kim, BJ; Kim, J; Mastro, MA | 1 |
| Brown, MB; Chilcott, RP; Hider, RC; Jones, SA; Kong, XL; Staff, K | 1 |
| Boukortt, A; Hayn, R; Virot, F | 1 |
| Legrand, SB | 1 |
| Catlow, CR; Miskufova, M; Sokol, AA; Walsh, A | 1 |
| Boston, RC; Fecteau, ME; Fyock, TL; McAdams, SC; Sweeney, RW; Whitlock, RH | 1 |
| Busetto, R; Iacopetti, I; Maritan, P; Pollina, GF; Zagotto, G | 1 |
| Chueh, YL; Feng, SW; Jarasiunas, K; Malinauskas, T; Wang, HC; Yu, XY | 1 |
| Ahn, J; Eddy, CR; Feigelson, B; Hite, JK; Kim, J; Klein, PB; Mastro, MA | 1 |
| Abidin, MS; Hashim, AM; Rahman, SF; Sadoh, T; Sharifabad, ME | 1 |
| Choi, HW; Li, KH; Ma, Z | 1 |
| Huang, Y; Jung, YH; Kim, D; Kim, HS; Kim, TI; Li, Y; Pao, HA; Rogers, JA; Song, IS; Song, J; Wierer, JJ | 1 |
| Arízaga, GG; López, OE; Oviedo, MJ | 1 |
| Akasaka, T; Gotoh, H; Kobayashi, Y; Yamamoto, H | 1 |
| Hane, K; Iwabuchi, A; Kawaguchi, H; Nakazato, H | 1 |
| Chen, W; de Léséleuc, L; Harris, G; KuoLee, R | 1 |
| Ambacher, O; Anzt, J; Cimalla, V; Linkohr, S; Pletschen, W; Schwarz, SU | 1 |
| Antunes, LC; Imperi, F; Minandri, F; Visca, P | 1 |
| Chang, HC; He, JH; Ho, CH; Hsing, MK; Kang, CF; Lai, KY; Lien, DH; Lin, CA | 1 |
| Ardila, G; Han, W; Hinchet, R; Montès, L; Mouis, M; Pradel, K; Songmuang, R; Wang, ZL; Yang, Y; Zhang, F; Zhang, Y; Zhou, YS | 1 |
| Horng, RH; Kuo, YW; Shen, KC; Wuu, DS | 1 |
| Aimez, V; André, N; Bay, A; Belarouci, A; Francis, LA; Sarrazin, M; Vigneron, JP | 1 |
| Choi, Y; Jeon, KS; Kang, MG; Lee, JS; Ryu, HY | 1 |
| DenBaars, SP; Feezell, D; Fujito, K; Nakamura, S; Speck, JS; Van de Walle, CG; Yan, Q; Zhao, Y | 1 |
| Fu, Q; Ji, C; Jiang, T; Liu, D; Meng, Q; Ren, Z; Wang, K; Wu, X; Xue, F; Yang, L; Zhang, J; Zhou, L | 1 |
| Bauters, A; Holt, DJ; Rogosnitzky, M; Zerbib, P | 1 |
| Balogh, S; Csikós, A; Radványi, I | 1 |
| Boogerd, FC; García-Contreras, R; Hashimoto, T; Hernández-González, IL; Jasso-Chávez, R; Lira-Silva, E; Maeda, T; Moreno-Sánchez, R; Sheng, L; Wood, TK | 1 |
| Abdalla, MY; Britigan, BE; Kesavalu, B; Olakanmi, O; Pasula, R; Schlesinger, LS | 1 |
| Chen, W; de Léséleuc, L; Harris, G; KuoLee, R; Xu, HH | 1 |
| Cho, KR; Choi, IW; Choi, JH; Kim, MH; Kim, YJ; Lee, JH; Lee, WJ; Lim, JG; Park, SG; Roh, KH; Seo, SK | 1 |
| Aceto, HW; Bernstein, LR; Fecteau, ME; Sweeney, RW | 1 |
| Feng, XH; Feng, YX; Yu, XZ | 1 |
| Yu, XZ; Zhang, XH | 1 |
| Bonchi, C; Frangipani, E; Imperi, F; Visca, P | 1 |
| Chen, R; Liao, L; Qiu, Y; Zhu, Y | 1 |
| Feng, X; Fu, Q; Li, J; Wang, GB; Zhang, J | 1 |
| Bernstein, LR; Fecteau, ME; Monk, CS; Sweeney, RW | 1 |
| Boukhechba, F; Bouler, JM; Didak, B; Guberovic, I; Schmid-Alliana, A; Schmid-Antomarchi, H; Scimeca, JC; Strazic-Geljic, I; Verron, E | 1 |
| Bonchi, C; Frangipani, E; Runci, F; Visaggio, D; Visca, P | 1 |
| Guo, M; Li, C; Shao, Y; Song, T; Zhang, W; Zhao, X | 1 |
| Angarita-Zapata, V; Belmont-Díaz, J; Cazares, A; Coria-Jiménez, R; García-Contreras, R; Jasso-Chávez, R; López-Jacome, LE; Maeda, T; Sanchez-Torres, V; Tovar-García, A | 1 |
| Burrows, LL; Chan, DCK; Guo, I | 1 |
| Cho, CY; Ha, MW; Kang, W; Kim, Y; Lee, HH; Lee, K; Lee, P; Park, KH; Woo, K; Yoon, TS | 1 |
| Chen, L; Dong, J; Gong, Z; Huang, Y; Wang, B; Wang, Z; Xiang, B; Yang, J | 1 |
| Chang, H; Hou, Y; Li, L; Li, M; Rao, W; Yong, N | 1 |
| Drlica, K; Feng, J; Li, J; Liu, Z; Lv, Y; Wang, D; Wang, W; Wu, L; Xue, Y; Zeng, J; Zhao, X | 1 |
| Costabile, G; d'Emmanuele di Villa Bianca, R; Frangipani, E; Mitidieri, E; Provenzano, R; Sorrentino, R; Turnaturi, C; Ungaro, F; Vanacore, D; Visaggio, D; Visca, P | 1 |
| Li, N; Lin, Y; Shan, H; Xia, W; Yin, F; Yu, X; Zhou, Z | 1 |
| Britigan, BE; Choi, SR; Narayanasamy, P; Scott, ZW; Talmon, GA | 1 |
| Costabile, G; d'Angelo, I; d'Emmanuele di Villa Bianca, R; Frangipani, E; Miro, A; Mitidieri, E; Provenzano, R; Quaglia, F; Sorrentino, R; Ungaro, F; Visaggio, D; Visca, P | 1 |
| Badmasti, F; Barzi, SM; Chiani, M; Mirabzadeh, E; Shafiei, M; Shamkani, F; Zafari, M | 1 |
52 review(s) available for gallium and gallium nitrate
| Article | Year |
|---|---|
Treatment of chemotherapy-refractory metastatic urothelial tumors.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Gallium; Humans; Interferon-alpha; Methotrexate; Urinary Bladder Neoplasms; Vinblastine | 1992 |
Management of acute hypercalcemia.
Topics: Acute Disease; Calcitonin; Diphosphonates; Fluid Therapy; Furosemide; Gallium; Humans; Hypercalcemia; Plicamycin | 1992 |
Gallium nitrate.
Topics: Gallium; Humans; Hypercalcemia; Neoplasms | 1992 |
Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer related hypercalcaemia.
Topics: Animals; Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Nephrotoxicity from chemotherapy: prevention and management.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Gallium; Humans; Ifosfamide; Kidney Diseases; Methotrexate; Mitomycin; Neoplasms; Nitrosourea Compounds; Plicamycin | 1991 |
Pharmacokinetics and therapeutic index of gallium nitrate.
Topics: Antineoplastic Agents; Gallium; Humans; Neoplasms | 1991 |
Studies on the mechanism of action of gallium nitrate.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Resorption; Gallium; Osteoclasts | 1991 |
Salmon calcitonin in the acute management of hypercalcemia.
Topics: Adrenal Cortex Hormones; Calcitonin; Calcium; Diphosphonates; Gallium; Humans; Hypercalcemia; Pamidronate; Plicamycin | 1990 |
New anticancer agents.
Topics: Acetamides; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Flavonoids; Gallium; Humans; Mitolactol; Mitoxantrone; Organoplatinum Compounds; Pentostatin; Quinazolines; Ribavirin; Trimetrexate; Vidarabine Phosphate | 1987 |
Gallium in the treatment of hypercalcemia and bone metastasis.
Topics: Animals; Bone Neoplasms; Gallium; Humans; Hypercalcemia; Neoplasms | 1989 |
[Tumoral hypercalcemia: physiopathology and treatment].
Topics: Bone and Bones; Bone Neoplasms; Bone Resorption; Calcitonin; Calcitriol; Calcium; Diphosphonates; Diuretics; Fluid Therapy; Gallium; Glucocorticoids; Humans; Hypercalcemia; Intestinal Absorption; Kidney Tubules; Middle Aged; Neoplasms; Parathyroid Hormone; Phosphates; Plicamycin; Prostaglandin Antagonists | 1985 |
Gallium nitrate: the second metal with clinical activity.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Gallium; Humans; Hypocalcemia; Kidney Diseases; Kinetics; Lymphoma; Tissue Distribution | 1986 |
Antimicrobial alternatives for calf diarrhea: iron chelators or competitors.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Chelating Agents; Deferoxamine; Diarrhea; Gallium; Gallium Radioisotopes; Guinea Pigs; Humans; Infant, Newborn; Intestinal Mucosa; Iron; Lactoferrin; Malabsorption Syndromes; Swine; Transferrin | 1985 |
Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs.
Topics: Antineoplastic Agents; Aspartic Acid; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Fluorouracil; Gallium; Humans; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Methotrexate; Phosphonoacetic Acid; Protein Binding; Tegafur | 1982 |
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
Palliative chemotherapy in advanced bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Gallium; Gemcitabine; Humans; Ifosfamide; Methotrexate; Paclitaxel; Palliative Care; Urinary Bladder Neoplasms; Vinblastine | 1995 |
The management of hypercalcemia of malignancy.
Topics: Bone Diseases, Metabolic; Bone Resorption; Cytokines; Diphosphonates; Gallium; Humans; Hypercalcemia; Neoplasms; Osteoclasts | 1995 |
Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Gallium; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Staging; Paclitaxel; Pyrimidines; Trimetrexate; Urinary Bladder Neoplasms; Vinblastine | 1995 |
Drug therapy of hypercalcemia due to malignancy.
Topics: Antineoplastic Agents; Calcitonin; Diphosphonates; Diuretics; Fluid Therapy; Gallium; Glucocorticoids; Humans; Hypercalcemia; Neoplasms; Paraneoplastic Syndromes; Plicamycin | 1994 |
New chemotherapeutic agents for the treatment of low-grade non-Hodgkin's lymphomas.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Depsipeptides; Gallium; Humans; Lymphoma, Non-Hodgkin; Mitoguazone; Paclitaxel; Peptides, Cyclic; Suramin | 1993 |
Treatment of pathological stage T3N+M0 bladder cancer: the case for observation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Gallium; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms | 1993 |
Update on the medical treatment of hypercalcemia of malignancy.
Topics: Animals; Antineoplastic Agents; Calcitonin; Diphosphonates; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasm Proteins; Neoplasms; Neoplasms, Experimental; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Treatment Outcome | 1993 |
Medical treatment for Paget's disease of bone.
Topics: Calcitonin; Diphosphonates; Gallium; Humans; Osteitis Deformans | 1993 |
Pathogenesis and management of cancer associated hypercalcaemia.
Topics: Antineoplastic Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Diuretics; Etidronic Acid; Fluid Therapy; Gallium; Humans; Hypercalcemia; Neoplasms; Pamidronate; Phosphates; Plicamycin; Research | 1994 |
Ifosfamide in the treatment of bladder cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Gallium; Humans; Ifosfamide; Multicenter Studies as Topic; Paclitaxel; Remission Induction; Renal Insufficiency; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Local cellular immunology of experimental transplant vascular sclerosis.
Topics: Animals; Antibodies; Antibodies, Monoclonal; CD4 Antigens; Cytokines; Endothelium, Vascular; Fibrosis; Gallium; Graft Rejection; Graft Survival; Heart Transplantation; Hyperplasia; Immunity, Cellular; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; RNA, Messenger; Sclerosis; Spleen; T-Lymphocytes; Transplantation Chimera; Transplantation, Heterotopic; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 1996 |
Chemotherapy for advanced bladder carcinoma: new molecules and regimens.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Folic Acid Antagonists; Gallium; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Methotrexate; Paclitaxel; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Acute management of cancer-related hypercalcemia.
Topics: Calcitonin; Diphosphonates; Fluid Therapy; Gallium; Glucocorticoids; Humans; Hypercalcemia; Neoplasms; Plicamycin | 1996 |
Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Deferoxamine; Gallium; Humans; Iron; Mice; Neoplasms, Experimental; Receptors, Transferrin; Siderophores | 1997 |
Gallium nitrate for the treatment of bone metastases.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Bone Resorption; Gallium; Humans; Rats | 1997 |
New chemotherapy regimens for advanced bladder cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Folic Acid Antagonists; Gallium; Gemcitabine; Humans; Ifosfamide; Methotrexate; Urinary Bladder Neoplasms; Vinblastine | 1998 |
New approaches to treatment of metastatic bladder cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gallium; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Metastasis; Taxoids; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Therapeutic uses of gallium nitrate: past, present, and future.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Disease Models, Animal; Gallium; Humans; Immunosuppressive Agents; Mice | 1999 |
Pathogenesis and pharmacological treatment of bone pain in skeletal metastases.
Topics: Analgesics; Analgesics, Opioid; Animals; Bone Neoplasms; Calcitonin; Diphosphonates; Female; Gallium; Humans; Male; Pain, Intractable; Palliative Care | 2001 |
Conventional treatment of hypercalcemia of malignancy.
Topics: Calcitonin; Clinical Protocols; Diphosphonates; Drug Costs; Fluid Therapy; Gallium; Humans; Hydrocortisone; Hypercalcemia; Imidazoles; Neoplasms; Nucleic Acid Synthesis Inhibitors; Plicamycin; Prednisone; Rehydration Solutions; Zoledronic Acid | 2001 |
Bone lesions in malignant diseases--II. Therapeutic management.
Topics: Bone Diseases; Calcitonin; Diphosphonates; Gallium; Humans; Hypercalcemia; Neoplasms | 2002 |
Gallium nitrate revisited.
Topics: Antineoplastic Agents; Bone and Bones; Gallium; Humans; Hypercalcemia; Lymphoma; Neoplasms | 2003 |
The effects of gallium nitrate on bone resorption.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Resorption; Gallium; Humans; Osteitis Deformans; Osteoclasts | 2003 |
Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
Topics: Antineoplastic Agents; Gallium; Humans; Hypercalcemia; Neoplasms; Randomized Controlled Trials as Topic | 2003 |
Gallium nitrate in multiple myeloma: prolonged survival in a cohort of patients with advanced-stage disease.
Topics: Antineoplastic Agents; Gallium; Humans; Multiple Myeloma; Survival Analysis | 2003 |
Gallium nitrate in the treatment of lymphoma.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Gallium; Humans; Lymphoma | 2003 |
Gallium nitrate in the treatment of bladder cancer.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Gallium; Humans; Urinary Bladder Neoplasms | 2003 |
Gallium nitrate for the treatment of non-Hodgkin's lymphoma.
Topics: Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Gallium; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic | 2004 |
Gallium and other main group metal compounds as antitumor agents.
Topics: Antineoplastic Agents; Gallium; Humans; Hypercalcemia; Inorganic Chemicals; Neoplasms; Organometallic Compounds | 2004 |
Targeting apoptosis and DNA synthesis: understanding treatment concepts and nursing considerations.
Topics: Antineoplastic Agents; Apoptosis; DNA Replication; Gallium; Genes, bcl-2; Humans; Neoplasms; Nucleic Acid Synthesis Inhibitors | 2004 |
Gallium compounds as antineoplastic agents.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Gallium; Humans; Lymphoma; Urinary Bladder Neoplasms | 2004 |
Apoptotic mechanisms of gallium nitrate: basic and clinical investigations.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Gallium; Humans; Hydroxyurea; In Vitro Techniques; Lymphoma; Lymphoma, Non-Hodgkin; Prognosis; Treatment Outcome | 2004 |
[Hypercalcemia in neoplastic and granulomatous diseases: pathogenesis and treatment options].
Topics: Animals; Antineoplastic Agents; Blood Volume; Calcitonin; Diphosphonates; Diuresis; Gallium; Glucocorticoids; Granuloma; Humans; Hypercalcemia; Neoplasms | 2005 |
Modern management of malignant hypercalcemia.
Topics: Bone Density Conservation Agents; Calcitonin; Clinical Protocols; Diphosphonates; Fluid Therapy; Gallium; Humans; Hypercalcemia; Imidazoles; Neoplasms; Palliative Care; Pamidronate; Parathyroid Hormone-Related Protein; Zoledronic Acid | 2011 |
Gallium-containing anticancer compounds.
Topics: Antineoplastic Agents; Apoptosis; Clinical Trials as Topic; Coordination Complexes; Gallium; Humans; Iron; Lymphoma, Non-Hodgkin; Reactive Oxygen Species; Receptors, Transferrin; Ribonucleotide Reductases; Urinary Bladder Neoplasms | 2012 |
[The significance of early diagnosis of cancer-related hypercalcaemia].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Calcium; Denosumab; Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Early Diagnosis; Fluid Therapy; Gallium; Humans; Hypercalcemia; Incidence; Neoplasms; Osteolysis; Palliative Care; Prevalence; RANK Ligand | 2013 |
Gallium and its competing roles with iron in biological systems.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Biological Transport; Drug Evaluation; Drug Screening Assays, Antitumor; Gallium; Gallium Isotopes; Homeostasis; Humans; Iron; Mice; Mitochondria; Neoplasms; Nonheme Iron Proteins; Rats; Transferrin | 2016 |
28 trial(s) available for gallium and gallium nitrate
| Article | Year |
|---|---|
Gallium nitrate.
Topics: Gallium; Humans; Hypercalcemia; Neoplasms | 1992 |
Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Administration Schedule; Drug Evaluation; Gallium; Humans; Uremia; Urinary Bladder Neoplasms | 1991 |
A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
Topics: Adult; Aged; Analysis of Variance; Calcium; Creatinine; Double-Blind Method; Etidronic Acid; Female; Gallium; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Phosphates; Regression Analysis | 1991 |
Clinical trials of gallium nitrate in patients with cancer-related hypercalcemia.
Topics: Antineoplastic Agents; Calcitonin; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Evaluation; Female; Gallium; Humans; Male; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms | 1991 |
Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate.
Topics: Aged; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Transitional Cell; Gallium; Humans; Infusions, Intravenous; Middle Aged; Urinary Bladder Neoplasms | 1991 |
Use of gallium to treat Paget's disease of bone: a pilot study.
Topics: Aged; Alkaline Phosphatase; Antineoplastic Agents; Bone Regeneration; Bone Resorption; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Gallium; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pilot Projects; Time Factors | 1990 |
A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Gallium; Humans; Middle Aged; Uterine Cervical Neoplasms | 1991 |
Study in 25 patients shows gallium nitrate superior therapy for hypercalcemia in cancer patients.
Topics: Antineoplastic Agents; Calcium; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasms | 1990 |
Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
Topics: Adult; Aged; Calcitonin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Gallium; Glucocorticoids; Humans; Hypercalcemia; Male; Middle Aged; Paraneoplastic Syndromes; Random Allocation | 1988 |
Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnover.
Topics: Adenocarcinoma; Aged; Bone and Bones; Bone Neoplasms; Bone Resorption; Calcium; Clinical Trials as Topic; Creatinine; Gallium; Humans; Hydroxyproline; Male; Middle Aged; Phosphorus; Prostatic Neoplasms | 1987 |
Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Evaluation; Gallium; Humans; Lymphoma; Middle Aged | 1986 |
Gallium nitrate: the second metal with clinical activity.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Gallium; Humans; Hypocalcemia; Kidney Diseases; Kinetics; Lymphoma; Tissue Distribution | 1986 |
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
Ribonucleotide reductase inhibition in the treatment of advanced prostate cancer: an experimental approach with hydroxyurea and gallium nitrate in 20 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Gallium; Humans; Hydroxyurea; Male; Middle Aged; Prostatic Neoplasms; Ribonucleotide Reductases | 1995 |
A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Resorption; Creatinine; Dose-Response Relationship, Drug; Female; Gallium; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Peptides; Prospective Studies; Quality of Life | 1995 |
Treatment of patients with advanced Paget's disease of bone with two cycles of gallium nitrate.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Dose-Response Relationship, Drug; Gallium; Humans; Hydroxyproline; Injections, Subcutaneous; Middle Aged; Osteitis Deformans; Treatment Outcome | 1994 |
A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Administration Schedule; Female; Gallium; Humans; Male; Middle Aged; Neoplasm Metastasis | 1993 |
Low-dose gallium nitrate for prevention of osteolysis in myeloma: results of a pilot randomized study.
Topics: Adult; Aged; Bone Density; Calcium; Female; Gallium; Humans; Male; Middle Aged; Multiple Myeloma; Osteolysis; Pilot Projects | 1993 |
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drugs, Investigational; Female; Gallium; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged | 1993 |
A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Drug Administration Schedule; Female; Gallium; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Remission Induction; United States; Uterine Cervical Neoplasms; Vomiting | 1995 |
Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drugs, Investigational; Female; Gallium; Humans; Imides; Infusions, Intravenous; Isoquinolines; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Naphthalimides; Organophosphonates; Survival Rate; Teniposide | 1995 |
Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Evaluation Studies as Topic; Female; Gallium; Humans; Hydroxyurea; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Fluorouracil; Gallium; Humans; Male; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome; Urologic Neoplasms; Vinblastine | 1997 |
Paclitaxel plus gallium nitrate and filgrastim in patients with refractory malignancies: a phase I trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Filgrastim; Gallium; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Recombinant Proteins | 1998 |
A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Blindness; Drug Administration Schedule; Gallium; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms | 1999 |
A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Gallium; Humans; Lung Neoplasms; Male; Middle Aged; Transferrin | 2000 |
Pharmacokinetics of gallium nitrate after oral administration in adult horses--pilot study.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Area Under Curve; Gallium; Half-Life; Horses; Polyamines; Pyridines | 2012 |
171 other study(ies) available for gallium and gallium nitrate
| Article | Year |
|---|---|
Ga3+ inhibits parathyroid hormone release without interacting with the Ca2+ receptor of the parathyroid cell.
Topics: Animals; Antineoplastic Agents; Calcium; Calcium-Binding Proteins; Cattle; Cell Membrane; Cyclic AMP; Fura-2; Gallium; Humans; In Vitro Techniques; Kinetics; Parathyroid Diseases; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms | 1992 |
Effect of gallium on the tyrosyl radical of the iron-dependent M2 subunit of ribonucleotide reductase.
Topics: Animals; Binding, Competitive; Cell Line; DNA Replication; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Free Radicals; Gallium; Iron; Mice; Quaternary Ammonium Compounds; Ribonucleotide Reductases; Tyrosine | 1992 |
Treatment with gallium nitrate: evidence for interference with iron metabolism in vivo.
Topics: Animals; Antineoplastic Agents; Blood Cells; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Drug Administration Schedule; Gallium; Humans; Iron; Lung Neoplasms; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, Transferrin; Urinary Bladder Neoplasms | 1992 |
Suppression of experimental autoimmune encephalomyelitis by gallium nitrate.
Topics: Animals; Autoimmune Diseases; Cell Division; Cell Line; Concanavalin A; Encephalomyelitis, Autoimmune, Experimental; Gallium; Lymphocyte Activation; Male; Myelin Basic Protein; Rats; Rats, Inbred Lew; T-Lymphocytes; Tuberculin | 1992 |
Effects of gallium nitrate on calcium transients in UMR-106 rat osteoblastic osteosarcoma cells.
Topics: Animals; Antineoplastic Agents; Calcium; Gallium; Osteosarcoma; Parathyroid Hormone; Prostaglandins F, Synthetic; Rats; Thrombin; Tumor Cells, Cultured | 1992 |
Long-term effects of gallium nitrate in patients with Paget's disease of bone.
Topics: Alkaline Phosphatase; Gallium; Humans; Osteitis Deformans | 1992 |
Developmental toxicity evaluation of gallium nitrate in mice.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Body Weight; Embryonic and Fetal Development; Female; Gallium; Male; Mice; Pregnancy | 1992 |
Lack of effect of gallium nitrate on bone density in a rat model of simulated microgravity.
Topics: Animals; Antineoplastic Agents; Bone Density; Bone Resorption; Gallium; Gravitation; Injections, Subcutaneous; Male; Osteoblasts; Osteoclasts; Posture; Rats; Rats, Inbred Strains | 1992 |
Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Biological Transport; Cell Division; Cell Line; Chlorides; Ferric Compounds; Gallium; Humans; Iron; Kinetics; Leukemia, Promyelocytic, Acute; Receptors, Transferrin; Transferrin | 1992 |
Evidence for arsenic as the immunosuppressive component of gallium arsenide.
Topics: Animals; Antibody Formation; Arsenic; Arsenicals; Arsenites; Cells, Cultured; Dose-Response Relationship, Drug; Female; Gallium; Immune Tolerance; Immunoglobulin M; Mice; Models, Biological; Oxalates; Oxalic Acid; Sodium Compounds; Spectrophotometry, Atomic; Spleen; Succimer; Tissue Distribution | 1991 |
Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
Topics: Antineoplastic Agents; Cell Division; Deferoxamine; Drug Synergism; Edetic Acid; Gallium; Humans; Iron; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured; Vidarabine Phosphate | 1990 |
Gallium nitrate inhibits bone resorption and collagen synthesis in neonatal mouse calvariae.
Topics: Animals; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Collagen; Dose-Response Relationship, Drug; Gallium; Glucuronidase; Interleukin-1; Mice; Organ Culture Techniques; Parathyroid Hormone; Peptide Fragments; Teriparatide; Thyroxine | 1991 |
Gallium nitrate, "the most potent agent available," approved by FDA for hypercalcemia of cancer.
Topics: Antineoplastic Agents; Gallium; Humans; Hypercalcemia; Neoplasms; United States; United States Food and Drug Administration | 1991 |
A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Gallium; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Remission Induction; Vomiting | 1991 |
Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3, and Ga(NO3)3 in rat subdermal model studies.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Calcinosis; Cardiomyopathies; Cattle; Chlorides; Ferric Compounds; Gallium; Glutaral; Lanthanum; Microscopy, Electron; Pericardium; Rats; Skin | 1991 |
Gallium nitrate in the treatment of cancer-related hypercalcemia.
Topics: Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Hazards of gallium for the treatment of Paget's disease of bone.
Topics: Aluminum; Antineoplastic Agents; Bone Diseases, Metabolic; Drug Administration Schedule; Gallium; Humans; Osteitis Deformans | 1990 |
Hazards of gallium for Paget's disease of bone.
Topics: Animals; Brain Chemistry; Drug Administration Schedule; Gallium; Injections, Subcutaneous; Osteitis Deformans; Random Allocation; Rats; Rats, Inbred Strains | 1990 |
Gallium for hypercalcemia of malignancy.
Topics: Combined Modality Therapy; Costs and Cost Analysis; Fluid Therapy; Gallium; Humans; Hypercalcemia; Neoplasms | 1991 |
Bone particles from gallium-treated rats are resistant to resorption in vivo.
Topics: Acid Phosphatase; Animals; Bone and Bones; Bone Density; Bone Matrix; Bone Resorption; Calcium; Gallium; Hypercalcemia; Male; Osteoclasts; Particle Size; Rats; Rats, Inbred Strains; Tartrates | 1991 |
Trace elemental analysis in bone using x-ray microscopy.
Topics: Animals; Bone Density; Calcium; Female; Gallium; Rats; Rats, Inbred Strains; Spectrometry, X-Ray Emission; Tibia; Trace Elements | 1990 |
Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Topics: Antineoplastic Agents; Biological Transport; Cell Division; Cell Line; Cell Survival; Drug Resistance; Electron Spin Resonance Spectroscopy; Gallium; Humans; Iron; Kinetics; Leukemia, Promyelocytic, Acute; Receptors, Transferrin; Ribonucleotide Reductases; Transferrin; Tumor Cells, Cultured | 1990 |
A promising new treatment for hypercalcemia.
Topics: Gallium; Humans; Hypercalcemia; Kidney Diseases | 1990 |
Gallium nitrate for advanced Paget disease of bone: effectiveness and dose-response analysis.
Topics: Aged; Alkaline Phosphatase; Creatinine; Dose-Response Relationship, Drug; Female; Gallium; Humans; Hydroxyproline; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Osteitis Deformans | 1990 |
Effect of gallium nitrate on the in vivo distribution of 67Ga in rats bearing inflammatory lesions.
Topics: Abscess; Animals; Ferric Compounds; Gallium; Gallium Radioisotopes; Male; Nitrates; Rats; Rats, Inbred Strains; Tissue Distribution; Turpentine | 1989 |
Combination iron depletion therapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chelating Agents; Drug Screening Assays, Antitumor; Female; Gallium; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoglobulin A; Iron Deficiencies; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Macrophages; Ovarian Neoplasms; Oxazoles; Receptors, Transferrin; Tumor Cells, Cultured | 1989 |
Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Erythrocyte Count; Female; Gallium; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged | 1989 |
Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
Topics: Adult; Bone Resorption; Calcium; Cyclic AMP; Female; Gallium; Humans; Hypercalcemia; Kidney; Male; Neoplasm Metastasis; Parathyroid Hormone; Parathyroid Neoplasms; Plicamycin | 1987 |
Gallium increases bone calcium and crystallite perfection of hydroxyapatite.
Topics: Animals; Body Weight; Bone and Bones; Calcium; Carbonates; Crystallization; Durapatite; Female; Gallium; Hydroxyapatites; Phosphates; Rats; X-Ray Diffraction | 1986 |
Bone modeling in gallium nitrate-treated rats.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone and Bones; Bone Resorption; Calcium; Cell Count; Gallium; Kidney; Male; Osteoclasts; Parathyroid Hormone; Rats | 1987 |
Effect of gallium on DNA synthesis by human T-cell lymphoblasts.
Topics: Antineoplastic Agents; Cell Division; Cell Line; Deoxyribonucleotides; Deoxyuridine; DNA Replication; Drug Screening Assays, Antitumor; Flow Cytometry; Gallium; Humans; T-Lymphocytes; Tritium; Uridine | 1988 |
Relative efficacy of chelating agents as antidotes for acute gallium nitrate intoxication.
Topics: Animals; Antidotes; Antineoplastic Agents; Chelating Agents; Gallium; Lethal Dose 50; Male; Mice | 1987 |
Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis.
Topics: Adult; Aged; Calcium; Creatinine; Dose-Response Relationship, Drug; Female; Gallium; Humans; Hypercalcemia; Kidney; Kinetics; Male; Middle Aged; Neoplasms; Phosphorus; Time Factors | 1986 |
Salvage chemotherapy of advanced lymphoma with investigational drugs: mitoguazone, gallium nitrate, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Gallium; Humans; Lymphoma; Middle Aged; Mitoguazone | 1987 |
Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases.
Topics: Adult; Aged; Antineoplastic Agents; Bone Development; Bone Neoplasms; Bone Resorption; Calcium; Female; Gallium; Humans; Hydroxyproline; Male; Middle Aged | 1987 |
Metabolic effects of gallium nitrate administered by prolonged infusion.
Topics: Antineoplastic Agents; Calcium; Gallium; Humans; Hypocalcemia; Lymphoma; Phosphorus | 1985 |
Phase II trial of gallium nitrate in patients with advanced malignant melanoma.
Topics: Abdominal Neoplasms; Adult; Aged; Calcium; Creatinine; Drug Evaluation; Electrolytes; Female; Gallium; Humans; Infusions, Parenteral; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Radionuclide Imaging; Skin Neoplasms | 1985 |
Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide.
Topics: Antibodies, Monoclonal; Cell Line; Cell Transformation, Neoplastic; Dimethyl Sulfoxide; Flow Cytometry; Gallium; Humans; Leukemia, Myeloid, Acute; Mitosis; Receptors, Cell Surface; Receptors, Transferrin | 1983 |
Administration of gallium nitrate by continuous infusion: lack of chronic nephrotoxicity confirmed by studies of enzymuria and beta 2-microglobulinuria.
Topics: Acetylglucosaminidase; Antineoplastic Agents; beta 2-Microglobulin; Gallium; Humans; Kidney; Leucyl Aminopeptidase | 1983 |
Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.
Topics: Animals; Bone Resorption; Calcium; Calcium Radioisotopes; Female; Gallium; Humans; Hypercalcemia; Hypocalcemia; Male; Neoplasms; Pilot Projects; Pregnancy; Rats | 1984 |
Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Creatinine; Drug Administration Schedule; Drug Evaluation; Gallium; Humans; Hypocalcemia; Infusions, Parenteral; Kidney Diseases; Lung Diseases; Lymphoma; Middle Aged | 1983 |
Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study.
Topics: Adolescent; Adult; Aged; Gallium; Hodgkin Disease; Humans; Lymphoma; Middle Aged | 1983 |
Tumor cell toxicity of stable gallium nitrate: enhancement by transferrin and protection by iron.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Clone Cells; Dose-Response Relationship, Drug; Gallium; Iron; Mice; Sarcoma, Experimental; Time Factors; Transferrin | 1982 |
Relationship of iron metabolism to tumor cell toxicity of stable gallium salts.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Female; Ferric Compounds; Gallium; Gallium Radioisotopes; Iron; Mice; Mice, Inbred BALB C; Sarcoma, Experimental; Transferrin | 1981 |
Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Gallium; Humans; Neoplasm Metastasis | 1982 |
Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Drug Evaluation; Female; Gallium; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1982 |
Pharmacokinetics of gallium nitrate in man.
Topics: Adolescent; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Gallium; Half-Life; Humans; Infusions, Parenteral; Kinetics; Neoplasms; Tissue Distribution | 1980 |
Phase I-II clinical trial of gallium nitrate (NSC-15200).
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Gallium; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms | 1980 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
Topics: Antineoplastic Agents; Biological Transport, Active; Cell Division; Deferoxamine; Gallium; Humans; Iron; Iron Chelating Agents; Isoniazid; Pyridoxal; Transferrin; Tumor Cells, Cultured | 1995 |
Hypercalcemia.
Topics: Bone Resorption; Calcitonin; Cyclooxygenase Inhibitors; Diphosphonates; Fluid Therapy; Gallium; Glucocorticoids; Humans; Hypercalcemia; Peritoneal Dialysis; Phosphates; Plicamycin; Renal Dialysis | 1994 |
Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells.
Topics: Apoptosis; Chromatin; Deferoxamine; Ferric Compounds; Gallium; Humans; Insulin; Iron; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quaternary Ammonium Compounds; Recombinant Proteins | 1995 |
Ultrastructural and histomorphometric evaluations of gallium nitrate on bone in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Calcium; Disease Models, Animal; Dog Diseases; Dogs; Gallium; Hypercalcemia; Male; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Transplantation; Osteoblasts; Osteoclasts; Tumor Cells, Cultured | 1995 |
Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathologic human parathyroid cells.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Cytoplasm; Diphosphonates; Gallium; Humans; Hypercalcemia; Hyperparathyroidism; In Vitro Techniques; Middle Aged; Pamidronate; Parathyroid Hormone; Thyroid Gland | 1995 |
Normocalcemic effect of gallium nitrate in a hypercalcemic rat model.
Topics: Administration, Oral; Animals; Biological Availability; Calcium; Gallium; Hypercalcemia; Infusions, Intravenous; Infusions, Parenteral; Parathyroid Hormone; Parathyroidectomy; Rats | 1995 |
Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Drug Administration Schedule; Drug Synergism; Gallium; Humans; Kinetics; Neoplastic Stem Cells; Paclitaxel; Tumor Cells, Cultured | 1994 |
Cytotoxicity of gallium and indium ions compared with mercuric ion.
Topics: Animals; Cell Count; Cell Division; Cell Line; Colorimetry; Coloring Agents; Fibroblasts; Gallium; Indium; Mercury; Mercury Compounds; Mice; Microscopy, Electron, Scanning; Mitochondria; Nitrates; Oxidoreductases; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Thiazoles | 1994 |
Gallium nitrate delays the progression of microscopic disease in a human medulloblastoma murine model.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Gallium; Humans; Medulloblastoma; Mice; Mice, Nude; Neoplasm Transplantation | 1994 |
Differential effects of gallium nitrate on T lymphocyte and endothelial cell activation.
Topics: Antineoplastic Agents; Cell Communication; Endothelium, Vascular; Gallium; Gonads; Graft Rejection; Humans; Immune System; Immune Tolerance; Lymphocyte Activation; T-Lymphocytes; Veins | 1994 |
Gallium nitrate and spinal cord injury. A pilot study of efficacy using an experimental model.
Topics: Animals; Female; Gallium; Immunohistochemistry; Pilot Projects; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries | 1994 |
Effects of humoral hypercalcemia of malignancy and gallium nitrate on thyroid C cells in nude mice: immunohistochemical and ultrastructural investigations.
Topics: Adenocarcinoma; Animals; Gallium; Hypercalcemia; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Transplantation; Paraneoplastic Syndromes; Thyroid Gland | 1994 |
Effects of gallium nitrate in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Resorption; Calcium; Creatinine; Disease Models, Animal; Dogs; Gallium; Hypercalcemia; Lumbar Vertebrae; Mice; Mice, Nude; Osteoclasts; Paraneoplastic Syndromes; Parathyroid Hormone-Related Protein; Proteins; Tumor Necrosis Factor-alpha | 1994 |
Prevention of gallium toxicity by hyperhydration in treatment of medulloblastoma.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Cell Division; Cell Line; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Fluid Therapy; Gallium; Kidney; Medulloblastoma; Mice; Mitotic Index; Neoplasm Transplantation; Sodium Chloride; Water-Electrolyte Balance | 1994 |
The effects of gallium nitrate on osteopenia induced by ovariectomy and a low-calcium diet in rats.
Topics: Analysis of Variance; Animals; Bone Density; Bone Diseases, Metabolic; Calcium, Dietary; Disease Models, Animal; Female; Gallium; Osteoblasts; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia | 1994 |
Recovery from extreme hypercalcaemia.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Calcitonin; Female; Fluid Therapy; Gallium; Humans; Hypercalcemia | 1993 |
Gallium nitrate increases type I collagen and fibronectin mRNA and collagen protein levels in bone and fibroblast cells.
Topics: Adult; Animals; Animals, Newborn; Collagen; Fibroblasts; Fibronectins; Gallium; Gene Expression Regulation; Humans; Osteoblasts; Rats; Rats, Sprague-Dawley; RNA, Messenger; Skull; Transcription, Genetic | 1993 |
Evaluation of the reproductive toxicity of gallium nitrate in mice.
Topics: Animals; Dose-Response Relationship, Drug; Female; Fertility; Gallium; Injections, Subcutaneous; Male; Mice; Organ Size; Reproduction; Sperm Count; Sperm Motility; Spermatozoa; Testis | 1993 |
The effect of gallium nitrate on healing of vitamin D- and phosphate-deficient rickets in the immature rat.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Density; Calcification, Physiologic; Calcitriol; Calcium; Gallium; Hydroxycholecalciferols; Injections, Subcutaneous; Male; Osteocalcin; Phosphates; Rats; Rats, Sprague-Dawley; Rickets; Vitamin D | 1993 |
Effect of gallium nitrate in vitro and in normal rats.
Topics: Animals; Bone Density; Bone Development; Cell Differentiation; Cell Division; Cells, Cultured; Collagen; Female; Gallium; Gene Expression; Osteoblasts; Osteocalcin; Random Allocation; Rats; Reference Values; RNA, Messenger; Tumor Cells, Cultured | 1993 |
Gallium nitrate regulates rat osteoblast expression of osteocalcin protein and mRNA levels.
Topics: Animals; Antineoplastic Agents; Blotting, Northern; Carrier Proteins; Cholecalciferol; Gallium; Osteoblasts; Osteocalcin; Osteopontin; Osteosarcoma; Rats; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Tumor Cells, Cultured | 1993 |
Gallium nitrate inhibits alkaline phosphatase activity in a differentiating mesenchymal cell culture.
Topics: Alkaline Phosphatase; Analysis of Variance; Animals; Antineoplastic Agents; Cartilage; Cell Differentiation; Cells, Cultured; Chick Embryo; Gallium; Mesoderm; Microscopy, Electron | 1993 |
Inhibition of protein tyrosine phosphatase by the antitumor agent gallium nitrate.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Calcium; Colonic Neoplasms; Gallium; Humans; Hydrogen Peroxide; Leukemia, T-Cell; Leukocyte Common Antigens; Mice; Protein Tyrosine Phosphatases; Signal Transduction; Tumor Cells, Cultured | 1993 |
Visual compatibility of gallium nitrate with selected drugs during simulated Y-site injection.
Topics: Antineoplastic Agents; Chemical Precipitation; Drug Incompatibility; Gallium; Humans; Infusions, Intravenous; Pharmaceutical Preparations; Visual Perception | 1993 |
Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; CD4 Antigens; Female; Gallium; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Myocardium; Transplantation, Homologous | 1996 |
Cytotoxicity of gallium nitrate in vitro using bladder cancer cells.
Topics: Antineoplastic Agents; Cell Death; Cell Division; Follow-Up Studies; Gallium; Humans; Receptors, Transferrin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells.
Topics: Antibodies, Monoclonal; Carcinoma, Small Cell; Cell Division; Culture Media; Gallium; Growth Inhibitors; Humans; Lung Neoplasms; Neoplasm Proteins; Receptors, Transferrin; Transferrin; Tumor Cells, Cultured | 1996 |
Modulation of in vitro and in vivo T-cell responses by transferrin-gallium and gallium nitrate.
Topics: Animals; Bone Marrow Transplantation; Drug Evaluation, Preclinical; Gallium; Graft vs Host Disease; Humans; Immunosuppressive Agents; Interleukin-2; Killer Cells, Lymphokine-Activated; Lymphocyte Activation; Mice; Mice, Inbred AKR; Radiation Chimera; Receptors, Transferrin; T-Lymphocyte Subsets; Transferrin; Up-Regulation | 1996 |
Effect of gallium nitrate therapy on Ga-67 scintigraphic detection of lymphoma: case report.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Gallium; Gallium Radioisotopes; Humans; Hydroxyurea; Leukemia, Lymphocytic, Chronic, B-Cell; Radionuclide Imaging; Tomography, X-Ray Computed | 1997 |
In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Drug Synergism; Gallium; Humans; Ketoconazole; Male; Prostatic Neoplasms; Time Factors; Tumor Cells, Cultured | 1997 |
Resistance to the antitumor agent gallium nitrate in human leukemic cells is associated with decreased gallium/iron uptake, increased activity of iron regulatory protein-1, and decreased ferritin production.
Topics: Antineoplastic Agents; Biological Transport; Cell Survival; Drug Resistance, Neoplasm; Ferritins; Gallium; Gene Expression Regulation, Neoplastic; Humans; Iron; Iron Regulatory Protein 1; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Kinetics; Leukemia; Receptors, Transferrin; RNA-Binding Proteins; RNA, Messenger; Transcription, Genetic; Transferrin; Tumor Cells, Cultured | 1997 |
Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Autoimmunity; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Cytokines; Female; Gallium; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoantibodies; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Phenotype; RNA, Messenger; Spleen; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Transplantation, Homologous; Transplantation, Isogeneic | 1997 |
Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection.
Topics: Animals; Gallium; Graft Rejection; Heart Transplantation; Hypersensitivity, Delayed; Immunization; Immunocompetence; Immunosuppression Therapy; Immunosuppressive Agents; Isoantigens; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Skin Transplantation; T-Lymphocytes; Tetanus Toxoid | 1997 |
In vitro investigations of new therapeutic agents on bladder tumor cell lines.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Gallium; Humans; Methotrexate; Paclitaxel; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1997 |
Gallium nitrate optic neuropathy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Gallium; Humans; Male; Optic Nerve Diseases; Prednisone; Prostatic Neoplasms; Scotoma; Vision Disorders | 1997 |
Gallium nitrate suppresses lupus in MRL/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Cell Division; Female; Gallium; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocytes; Male; Mice; Mice, Inbred MRL lpr; Organ Size; Osteogenesis; Random Allocation; Spleen; Tibia | 1997 |
Antineoplastic drugs that interfere with iron metabolism in cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cisplatin; Clinical Trials as Topic; Daunorubicin; Deferoxamine; Female; Gallium; Humans; Indium; Iron; Rats; Transferrin; Tumor Cells, Cultured | 1997 |
Effect of gallium nitrate on experimental autoimmune uveitis.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Arrestin; Autoimmune Diseases; Choroid; Gallium; Immunity, Cellular; Immunization; Male; Rats; Rats, Inbred Lew; Retina; Uveitis | 1997 |
Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
Topics: Animals; Antibodies, Monoclonal; Female; Gallium; Graft Rejection; Graft Survival; Heart Transplantation; Hypersensitivity, Delayed; Immunosuppression Therapy; Immunosuppressive Agents; Isoantigens; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Time Factors; Transplantation, Heterotopic; Transplantation, Homologous | 1998 |
Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
Topics: Antineoplastic Agents; Benzamidines; Cell Division; Deoxycytidine; Drug Synergism; Enzyme Inhibitors; Gallium; Gemcitabine; Humans; Hydroxamic Acids; Hydroxyurea; Oximes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured | 1998 |
Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
Topics: Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gallium; Humans; Isoniazid; Leukemia, Lymphoid; Pyridoxal; Transferrin; Tumor Cells, Cultured | 1996 |
Gallium nitrate suppresses the production of nitric oxide and liver damage in a murine model of LPS-induced septic shock.
Topics: Animals; Gallium; Interferon-gamma; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Shock, Septic; Tumor Necrosis Factor-alpha | 1999 |
The effect of gallium nitrate on synoviocyte MMP activity.
Topics: Animals; Cell Line; Collagenases; Gallium; Gelatin; Immunosuppressive Agents; Interleukin-1; Matrix Metalloproteinases; Rabbits; Synovial Membrane; Tetradecanoylphorbol Acetate | 2000 |
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
Topics: Cells, Cultured; Culture Media; Gallium; Humans; Iron; Macrophages; Macrophages, Alveolar; Microscopy, Electron, Scanning; Monocytes; Mycobacterium avium Complex; Mycobacterium tuberculosis; Transferrin | 2000 |
The push-and-pull mechanism to scavenge redox-active transition metals: a novel concept in myocardial protection.
Topics: Analysis of Variance; Animals; Cardioplegic Solutions; Deferoxamine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Free Radical Scavengers; Gallium; Heart Arrest, Induced; Heart Function Tests; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Wistar; Recovery of Function; Reference Values; Reperfusion Injury; Sensitivity and Specificity; Statistics, Nonparametric; Zinc Compounds | 2001 |
Gallium diffusion in human root dentin: quantitative measurements by pulsed Nd:YAG laser ablation combined with an inductively coupled plasma mass spectrometer.
Topics: Dental Pulp Cavity; Dentin; Gallium; Humans; Lasers; Mass Spectrometry; Osteoclasts; Root Resorption | 2000 |
Effects of heat shock, stannous chloride, and gallium nitrate on the rat inflammatory response.
Topics: Animals; Cell Adhesion; Cytoprotection; Endothelium, Vascular; Gallium; Heat-Shock Response; Hemodynamics; Hot Temperature; Hyperthermia, Induced; Immunoblotting; Immunosuppressive Agents; Inflammation; Leukocytes; Male; N-Formylmethionine Leucyl-Phenylalanine; Rats; Rats, Wistar; Tin Compounds | 2001 |
Effects of gallium and mercury ions on transport systems.
Topics: Amino Acid Transport Systems; Amino Acid Transport Systems, Basic; Amino Acids; Analysis of Variance; Animals; Betaine; Carrier Proteins; DNA-Binding Proteins; GABA Plasma Membrane Transport Proteins; Gallium; Glucose; Ion Channels; Ion Transport; Membrane Glycoproteins; Membrane Proteins; Mercuric Chloride; Mercury; Monosaccharide Transport Proteins; Oocytes; Phosphate Transport Proteins; Phosphates; Potassium Channel Blockers; Sodium; Sodium Channels; Sodium-Glucose Transporter 1; Sodium-Phosphate Cotransporter Proteins; Statistics as Topic; Symporters; Transcription Factors; Xenopus | 2001 |
Gallium nitrate accelerates partial thickness wound repair and alters keratinocyte integrin expression to favor a motile phenotype.
Topics: Animals; Cell Culture Techniques; Cell Differentiation; Cell Division; Cell Movement; Collagen Type I; Epidermal Cells; Fibronectins; Flow Cytometry; Gallium; Humans; Integrins; Keratinocytes; Ki-67 Antigen; Skin; Swine; Wound Healing | 2002 |
Extended survival in advanced-stage multiple myeloma patients treated with gallium nitrate.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Cohort Studies; Drug Evaluation; Female; Gallium; Humans; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Survival Analysis; Treatment Outcome | 2002 |
Genta incorporated. Gallium therapeutics: take two.
Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase II as Topic; Gallium; Humans; Neoplasms | 2002 |
Screw dislocations in GaN grown by different methods.
Topics: Gallium; Image Processing, Computer-Assisted; Microscopy, Electron | 2004 |
Activity of gallium nitrate in refractory peripheral T-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Gallium; Humans; Lymphoma, T-Cell; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Elimination of arthritis pain and inflammation for over 2 years with a single 90 min, topical 14% gallium nitrate treatment: case reports and review of actions of gallium III.
Topics: Arthralgia; Arthritis; Female; Gallium; Humans; Immunosuppressive Agents; Inflammation; Longitudinal Studies; Male; Middle Aged; Treatment Outcome | 2005 |
Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediates.
Topics: Antineoplastic Agents; Biological Transport; Cell Proliferation; Drug Resistance, Neoplasm; Gallium; Gallium Radioisotopes; HL-60 Cells; Humans; Iron; Iron Radioisotopes | 2006 |
Antimicrobial activity of gallium against virulent Rhodococcus equiin vitro and in vivo.
Topics: Actinomycetales Infections; Animals; Female; Gallium; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rhodococcus equi | 2006 |
Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Estrogen Receptor Modulators; Female; Gallium; Humans; Hypercalcemia; Middle Aged; Tamoxifen | 2006 |
Effect of gallium nitrate on tamoxifen induced hypercalcemia in rats bearing mammary tumor.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Calcium; Female; Gallium; Hypercalcemia; Mammary Neoplasms, Animal; Rats; Rats, Sprague-Dawley; Tamoxifen | 2006 |
Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition.
Topics: Antineoplastic Agents; bcl-2-Associated X Protein; Caspase 3; Caspase Inhibitors; Cell Death; Cytochromes c; Dose-Response Relationship, Drug; Gallium; Humans; Iron; Jurkat Cells; Lymphoma, Non-Hodgkin; Mitochondria; Proteasome Endopeptidase Complex; Receptors, Transferrin; Signal Transduction; Tumor Cells, Cultured | 2006 |
Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate.
Topics: Antineoplastic Agents; Blotting, Northern; Cation Transport Proteins; Cell Proliferation; DNA-Binding Proteins; DNA, Complementary; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Gallium; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Leukemia, Lymphoid; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Metallothionein; Oligonucleotide Array Sequence Analysis; Transcription Factor MTF-1; Transcription Factors; Transcription, Genetic | 2007 |
Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Evaluation; Drug Resistance, Neoplasm; Gallium; Humans; Lymphoma; Organometallic Compounds; Pyrones; Receptors, Transferrin; Tumor Suppressor Protein p53 | 2007 |
Microscopic investigation of the use of gallium nitrate for root surface treatment in rat teeth submitted to delayed replantation.
Topics: Administration, Topical; Animals; Fluorides, Topical; Gallium; Immunosuppressive Agents; Incisor; Male; Maxilla; Random Allocation; Rats; Rats, Wistar; Root Resorption; Sodium Fluoride; Surface Properties; Time Factors; Tooth Ankylosis; Tooth Replantation; Tooth Root; Tooth, Nonvital; Treatment Outcome; Wound Healing | 2007 |
A hypothesis for anti-nanobacteria effects of gallium with observations from treating kidney disease.
Topics: Bacteria; Gallium; Humans; Kidney Calculi; Models, Theoretical | 2008 |
Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Gallium; Gene Expression Regulation, Neoplastic; Heme Oxygenase (Decyclizing); Humans; Lymphoma; Metallothionein; Oxidative Stress | 2008 |
Improved cultural selectivity of medically significant fungi by suppression of contaminating bacterial flora employing gallium (III) nitrate.
Topics: Agar; Bacteria; Culture Media; Drug Resistance, Bacterial; Gallium; Humans; Iron; Microbiological Techniques; Mitosporic Fungi; Mycoses; Sensitivity and Specificity; Trace Elements | 2009 |
Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.
Topics: Acinetobacter baumannii; Animals; Burns; Female; Gallium; Mice; Organometallic Compounds; Pseudomonas Infections; Pyrones; Staphylococcus aureus | 2009 |
[LO phonon-plasmon coupled mode in hexagonal IngaN alloy].
Topics: Alloys; Crystallization; Gallium; Light; Nanostructures; Nanotechnology; Scattering, Radiation; Spectrum Analysis, Raman; Surface Plasmon Resonance | 2009 |
The serum protein binding of pharmacologically active gallium(III) compounds assessed by hyphenated CE-MS techniques.
Topics: Antineoplastic Agents; Binding, Competitive; Calibration; Electrophoresis, Capillary; Gallium; Gallium Isotopes; Humans; Hydrogen-Ion Concentration; Iron; Kinetics; Mass Spectrometry; Models, Biological; Organometallic Compounds; Oxyquinoline; Protein Binding; Serum Albumin; Transferrin | 2009 |
Negative differential resistance in GaN nanocrystals above room temperature.
Topics: Gallium; Nanoparticles; Nanotechnology; Temperature | 2009 |
Nucleation mechanism of GaN nanowires grown on (111) Si by molecular beam epitaxy.
Topics: Gallium; Microscopy, Electron, Scanning Transmission; Nanotechnology; Nanowires | 2009 |
Is gallium nitrate an effective kidney stone, calcified uterine fibroid, atherosclerosis and cataract anti-nanobacteria treatment? A case history and hypothesis.
Topics: Anti-Bacterial Agents; Atherosclerosis; Bacterial Infections; Cataract; Female; Gallium; Humans; Immunosuppressive Agents; Kidney Calculi; Middle Aged; Models, Biological; Treatment Outcome | 2010 |
High sensitivity hydrogen sensing with Pt-decorated porous gallium nitride prepared by metal-assisted electroless etching.
Topics: Electrochemical Techniques; Gallium; Gases; Hydrogen; Platinum; Porosity | 2010 |
Surface plasmon-enhanced light-emitting diodes using silver nanoparticles embedded in p-GaN.
Topics: Equipment Design; Gallium; Light; Metal Nanoparticles; Microscopy, Atomic Force; Nanotechnology; Optics and Photonics; Silver; Surface Plasmon Resonance | 2010 |
Single ZnO nanowire/p-type GaN heterojunctions for photovoltaic devices and UV light-emitting diodes.
Topics: Gallium; Lasers; Nanowires; Semiconductors; Ultraviolet Rays; Zinc Oxide | 2010 |
Transparent conductive graphene electrode in GaN-based ultra-violet light emitting diodes.
Topics: Electric Conductivity; Electrodes; Gallium; Graphite; Optical Devices; Ultraviolet Rays | 2010 |
Ga(III) complexes--the effect of metal coordination on potential systemic absorption after topical exposure.
Topics: Administration, Topical; Adult; Animals; Antineoplastic Agents; Coordination Complexes; Female; Gallium; Humans; In Vitro Techniques; Middle Aged; Permeability; Skin; Skin Absorption; Swine | 2011 |
Electronic structure and Jahn-Teller effect in GaN:Mn and ZnS:Cr.
Topics: Chromium Compounds; Electronics; Electrons; Gallium; Magnetics; Manganese Compounds; Models, Chemical; Models, Theoretical; Quantum Theory; Semiconductors; Sulfides; Zinc Compounds | 2011 |
Electron and hole stability in GaN and ZnO.
Topics: Electrons; Gallium; Models, Molecular; Oxidation-Reduction; Quantum Theory; Thermodynamics; Water; Zinc Oxide | 2011 |
Evaluation of the in vitro activity of gallium nitrate against Mycobacterium avium subsp paratuberculosis.
Topics: Animals; Cattle; Cattle Diseases; Culture Media; Gallium; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis | 2011 |
Suppression of surface recombination in surface plasmon coupling with an InGaN/GaN multiple quantum well sample.
Topics: Computer Simulation; Equipment Design; Fourier Analysis; Gallium; Immunosuppressive Agents; Light; Luminescence; Nanotechnology; Optics and Photonics; Quantum Theory; Surface Plasmon Resonance; Temperature | 2011 |
Single n-GaN microwire/p-Silicon thin film heterojunction light-emitting diode.
Topics: Gallium; Light; Microscopy; Nanowires; Optics and Photonics; Silicon; Spectrum Analysis | 2011 |
Open-gated pH sensor fabricated on an undoped-AlGaN/GaN HEMT structure.
Topics: Aluminum Compounds; Electrochemical Techniques; Electrons; Gallium; Hydrogen-Ion Concentration; Transistors, Electronic | 2011 |
Single-mode whispering gallery lasing from metal-clad GaN nanopillars.
Topics: Gallium; Lasers; Metals; Nanostructures; Nanotechnology; Silicon Dioxide | 2012 |
High-efficiency, microscale GaN light-emitting diodes and their thermal properties on unusual substrates.
Topics: Electronics; Gallium; Lighting; Nanotechnology | 2012 |
Electrical properties of polycrystalline GaN films functionalized with cysteine and stabilization of GaN nanoparticles in aqueous media.
Topics: Biosensing Techniques; Cysteine; Gallium; Hydrogen-Ion Concentration; Nanoparticles; Nanotechnology; Solutions | 2012 |
Extremely narrow violet photoluminescence line from ultrathin InN single quantum well on step-free GaN surface.
Topics: Gallium; Indium; Luminescent Agents; Microscopy, Atomic Force; Nanotechnology; Nitrates; Semiconductors; Surface Properties | 2012 |
Micro fluorescent analysis system integrating GaN-light-emitting-diode on a silicon platform.
Topics: Dimethylpolysiloxanes; Fluorescein-5-isothiocyanate; Gallium; Silicon; Spectrometry, Fluorescence | 2012 |
In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii.
Topics: 2,2'-Dipyridyl; Acinetobacter baumannii; Acinetobacter Infections; Animals; Gallium; Iron Chelating Agents; Mice; Transferrin | 2012 |
CIP (cleaning-in-place) stability of AlGaN/GaN pH sensors.
Topics: Aluminum Compounds; Biosensing Techniques; Diamond; Equipment Design; Food Industry; Gallium; Hydrogen-Ion Concentration; Nanostructures; Transistors, Electronic | 2013 |
In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gallium; Humans; Inhibitory Concentration 50; Iron; Larva; Moths; Repressor Proteins | 2012 |
Hierarchical structures consisting of SiO2 nanorods and p-GaN microdomes for efficiently harvesting solar energy for InGaN quantum well photovoltaic cells.
Topics: Gallium; Indium; Nanotubes; Nitrogen Compounds; Silicon Dioxide; Solar Energy; Surface Properties | 2012 |
Nano-Newton transverse force sensor using a vertical GaN nanowire based on the piezotronic effect.
Topics: Gallium; Microscopy, Atomic Force; Nanowires; Silicon; Silver | 2013 |
GaN light emitting diodes with wing-type imbedded contacts.
Topics: Aluminum Oxide; Contact Lenses; Equipment Design; Gallium; Humans; Indium; Semiconductors | 2013 |
Optimal overlayer inspired by Photuris firefly improves light-extraction efficiency of existing light-emitting diodes.
Topics: Animals; Equipment Design; Fireflies; Gallium; Indium; Light; Refractometry; Semiconductors | 2013 |
Dependence of efficiencies in GaN-based vertical blue light-emitting diodes on the thickness and doping concentration of the n-GaN layer.
Topics: Equipment Design; Gallium; Indium; Light; Semiconductors | 2013 |
Optical polarization characteristics of semipolar (3031) and (3031) InGaN/GaN light-emitting diodes.
Topics: Equipment Design; Gallium; Indium; Light; Lighting; Semiconductors | 2013 |
Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption.
Topics: Absorptiometry, Photon; Animals; Bone and Bones; Bone Density; Bone Resorption; Dexamethasone; Gallium; Glucocorticoids; Male; Osteoporosis; Rats; Rats, Sprague-Dawley; Yeasts | 2013 |
Gallium nitrate induces fibrinogen flocculation: an explanation for its hemostatic effect?
Topics: Blood Cells; Cells, Cultured; Dose-Response Relationship, Drug; Fibrinogen; Flocculation; Gallium; Hemostasis; Humans; Hydrogen-Ion Concentration; Nitric Acid; Whole Blood Coagulation Time | 2013 |
Isolation and characterization of gallium resistant Pseudomonas aeruginosa mutants.
Topics: Biofilms; DNA Transposable Elements; Drug Resistance, Bacterial; Gallium; Gene Deletion; Genetic Complementation Test; Microbial Sensitivity Tests; Mutagenesis, Insertional; Mutation; Pseudomonas aeruginosa | 2013 |
Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes.
Topics: Aconitate Hydratase; Animals; Antimetabolites; Antitubercular Agents; Bacterial Proteins; Colony Count, Microbial; Disease Models, Animal; Gallium; Iron; Liver; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Mycobacterium tuberculosis; Ribonucleotide Reductases; Spleen; Survival Analysis; Tuberculosis, Pulmonary | 2013 |
Serum resistance, gallium nitrate tolerance and extrapulmonary dissemination are linked to heme consumption in a bacteremic strain of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacteremia; Blood Bactericidal Activity; Cattle; Disease Models, Animal; Drug Resistance, Bacterial; Female; Gallium; Heme; Humans; Mice, Inbred C57BL; Pneumonia, Bacterial; Serum | 2014 |
Gallium nitrate ameliorates type II collagen-induced arthritis in mice.
Topics: Animals; Ankle Joint; Anti-Inflammatory Agents; Arthritis, Experimental; CD4-Positive T-Lymphocytes; Collagen Type II; Foot; Gallium; Immunoglobulin G; Interferon-gamma; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred DBA; NF-kappa B; Spleen; Tumor Necrosis Factor-alpha | 2014 |
Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro.
Topics: Anti-Bacterial Agents; Gallium; Mycobacterium avium subsp. paratuberculosis; Organometallic Compounds; Pyrones | 2014 |
Phytotoxicity and Transport of Gallium (Ga) in Rice Seedlings for 2-Day of Exposure.
Topics: China; Environmental Monitoring; Gallium; Hydroponics; Oryza; Plant Roots; Plant Shoots; Seedlings; Spectrophotometry, Atomic; Water Pollutants, Chemical | 2015 |
DNA-protein cross-links involved in growth inhibition of rice seedlings exposed to Ga.
Topics: DNA, Plant; Environmental Pollutants; Gallium; Hydroponics; Oryza; Plant Proteins; Plant Roots; Seedlings | 2015 |
Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum.
Topics: Anti-Bacterial Agents; Gallium; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Hydrolases; Pseudomonas aeruginosa; Quorum Sensing | 2015 |
The Inhibition of Escherichia coli Biofilm Formation by Gallium Nitrate-Modified Titanium.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Cell Proliferation; Coated Materials, Biocompatible; Diffusion; Escherichia coli; Gallium; Materials Testing; Nanoparticles; Particle Size; Prostheses and Implants; Surface Properties; Titanium | 2015 |
Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro.
Topics: Animals; Bone Density; Bone Resorption; Cell Death; Female; Gallium; Gene Expression Regulation; Immunohistochemistry; Osteoblasts; Osteoprotegerin; RANK Ligand; Rats, Sprague-Dawley; RNA, Messenger | 2016 |
Serum and tissue concentrations of gallium after oral administration of gallium nitrate and gallium maltolate to neonatal calves.
Topics: Administration, Oral; Animals; Animals, Newborn; Cattle; Gallium; Male; Mass Spectrometry; Organometallic Compounds; Pyrones | 2016 |
Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Communication; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clone Cells; Culture Media, Conditioned; Female; Gallium; Gene Expression Regulation, Neoplastic; Humans; Mice; Osteoclasts; Osteogenesis; Osteolysis; RAW 264.7 Cells; Transforming Growth Factor beta1 | 2016 |
Acinetobacter baumannii Biofilm Formation in Human Serum and Disruption by Gallium.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Gallium; Humans; Microbial Sensitivity Tests | 2017 |
Gallium(III) Nitrate Inhibits Pathogenic
Topics: Bacterial Proteins; Biological Transport; Cation Transport Proteins; Dose-Response Relationship, Drug; Gallium; Gene Expression Regulation, Bacterial; Homogentisic Acid; Iron; Melanins; Oxidation-Reduction; Siderophores; Vibrio | 2019 |
Characterization of gallium resistance induced in a Pseudomonas aeruginosa cystic fibrosis isolate.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Drug Repositioning; Drug Resistance, Bacterial; Gallium; Humans; Oligopeptides; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine | 2020 |
Forging New Antibiotic Combinations under Iron-Limiting Conditions.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ciclopirox; Clioquinol; Doxycycline; Gallium; Iron; Iron Deficiencies; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tropolone | 2020 |
Enhancement of cortisol measurement sensitivity by laser illumination for AlGaN/GaN transistor biosensor.
Topics: Aluminum Compounds; Biosensing Techniques; Gallium; Humans; Hydrocortisone; Lasers; Microfluidic Analytical Techniques; Transistors, Electronic | 2020 |
Research on the effect of TiO
Topics: Bacterial Adhesion; Biofilms; Escherichia coli; Gallium; Humans; Nanotubes; Staphylococcus aureus; Titanium | 2020 |
Superior antibacterial activity of gallium based liquid metals due to Ga
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Escherichia coli; Gallium; Humans; Indium; Intracellular Fluid; Microbial Sensitivity Tests; Reactive Oxygen Species; Staphylococcus aureus | 2021 |
Gain-of-Function Mutations in Acid Stress Response (
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Escherichia coli; Escherichia coli Proteins; Gain of Function Mutation; Gallium; Mutation; Protein Kinases | 2021 |
Intra-tracheal administration increases gallium availability in lung: implications for antibacterial chemotherapy.
Topics: Administration, Inhalation; Administration, Intravenous; Aerosols; Animals; Anti-Bacterial Agents; Biological Availability; Gallium; Lung; Male; Rats, Wistar; Tissue Distribution | 2021 |
Gallium Porphyrin and Gallium Nitrate Reduce the High Vancomycin Tolerance of MRSA Biofilms by Promoting Extracellular DNA-Dependent Biofilm Dispersion.
Topics: Biofilms; DNA; Gallium; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Porphyrins; Vancomycin | 2021 |
Combining Gallium Protoporphyrin and Gallium Nitrate Enhances
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Bacteria; Catalase; Fluorescent Dyes; Gallium; Humans; Mice; Nitrates; Protoporphyrins; Pseudomonas aeruginosa; Reactive Oxygen Species; Superoxide Dismutase | 2022 |
Boosting lung accumulation of gallium with inhalable nano-embedded microparticles for the treatment of bacterial pneumonia.
Topics: Animals; Cystic Fibrosis; Gallium; Humans; Lung; Male; Mice; Pneumonia, Bacterial; Rats | 2022 |
Enhanced anti-biofilm activity of the minocycline-and-gallium-nitrate using niosome wrapping against Acinetobacter baumannii in C57/BL6 mouse pneumonia model.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Gallium; Iran; Liposomes; Mice; Microbial Sensitivity Tests; Minocycline; Nitrates; Pneumonia | 2023 |